The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Joachim Boldt

Department of Anesthesiology and Intensive Care Medicine

Klinikum der Stadt Ludwigshafen

Ludwigshafen

Germany

[email]@gmx.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany. 2000 - 2010

References

  1. Safety of nonblood plasma substitutes: less frequently discussed issues. Boldt, J. Eur. J. Anaesthesiol (2010) [Pubmed]
  2. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients. Boldt, J., Mayer, J., Brosch, C., Lehmann, A., Mengistu, A. J. Cardiothorac. Vasc. Anesth. (2010) [Pubmed]
  3. Use of albumin: an update. Boldt, J. Br. J. Anaesth (2010) [Pubmed]
  4. Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery. Boldt, J., Suttner, S., Brosch, C., Lehmann, A., Mengistu, A. Br. J. Anaesth (2009) [Pubmed]
  5. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Boldt, J., Suttner, S., Brosch, C., Lehmann, A., Röhm, K., Mengistu, A. Anesth. Analg. (2009) [Pubmed]
  6. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate. Boldt, J. Intensive. Care. Med (2009) [Pubmed]
  7. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Boldt, J., Suttner, S., Brosch, C., Lehmann, A., Röhm, K., Mengistu, A. Intensive. Care. Med (2009) [Pubmed]
  8. Balanced hydroxyethylstarch preparations: are they all the same? In-vitro thrombelastometry and whole blood aggregometry. Boldt, J., Mengistu, A. Eur. J. Anaesthesiol (2009) [Pubmed]
  9. Saline versus balanced hydroxyethyl starch: does it matter? Boldt, J. Curr. Opin. Anaesthesiol (2008) [Pubmed]
  10. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Boldt, J., Brosch, C., Röhm, K., Lehmann, A., Mengistu, A., Suttner, S. Anesth. Analg. (2008) [Pubmed]
  11. Fluid management in burn patients: results from a European survey-more questions than answers. Boldt, J., Papsdorf, M. Burns (2008) [Pubmed]
  12. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Boldt, J., Brosch, C., Röhm, K., Papsdorf, M., Mengistu, A. Br. J. Anaesth (2008) [Pubmed]
  13. Identification of renal injury in cardiac surgery: the role of kidney-specific proteins. Boldt, J., Wolf, M. J. Cardiothorac. Vasc. Anesth. (2008) [Pubmed]
  14. Is correction of severe hypoalbuminemia necessary in the critically ill?. Boldt, J. Chin. Med. J. (2008) [Pubmed]
  15. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Boldt, J., Schöllhorn, T., Münchbach, J., Pabsdorf, M. Eur. J. Anaesthesiol (2007) [Pubmed]
  16. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Boldt, J., Brosch, C., Ducke, M., Papsdorf, M., Lehmann, A. Crit. Care Med. (2007) [Pubmed]
  17. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry. Boldt, J., Wolf, M., Mengistu, A. Anesth. Analg. (2007) [Pubmed]
  18. Pro: use of colloids in cardiac surgery. Boldt, J. J. Cardiothorac. Vasc. Anesth. (2007) [Pubmed]
  19. Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone. Boldt, J., Suttner, S. Expert. Opin. Pharmacother (2007) [Pubmed]
  20. Volume therapy in cardiac surgery: are Americans different from Europeans?. Boldt, J. J. Cardiothorac. Vasc. Anesth. (2006) [Pubmed]
  21. Do plasma substitutes have additional properties beyond correcting volume deficits?. Boldt, J. Shock (2006) [Pubmed]
  22. Fluid management of patients undergoing abdominal surgery--more questions than answers. Boldt, J. Eur. J. Anaesthesiol (2006) [Pubmed]
  23. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Boldt, J., Schölhorn, T., Mayer, J., Piper, S., Suttner, S. Anesth. Analg. (2006) [Pubmed]
  24. Plasma substitutes. Boldt, J., Suttner, S. Minerva. Anestesiol (2005) [Pubmed]
  25. Volume therapy in cardiac surgery. Boldt, J. Ann. Card. Anaesth (2005) [Pubmed]
  26. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Boldt, J., Ducke, M., Kumle, B., Papsdorf, M., Zurmeyer, E.L. Intensive. Care. Med (2004) [Pubmed]
  27. Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence. Boldt, J. Can. J. Anaesth (2004) [Pubmed]
  28. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Boldt, J., Brosch, C., Lehmann, A., Suttner, S., Isgro, F. Anesth. Analg. (2004) [Pubmed]
  29. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function?. Boldt, J., Priebe, H.J. Anesth. Analg. (2003) [Pubmed]
  30. Is kidney function altered by the duration of cardiopulmonary bypass?. Boldt, J., Brenner, T., Lehmann, A., Suttner, S.W., Kumle, B., Isgro, F. Ann. Thorac. Surg. (2003) [Pubmed]
  31. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Boldt, J., Brenner, T., Lehmann, A., Lang, J., Kumle, B., Werling, C. Intensive. Care. Med (2003) [Pubmed]
  32. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Boldt, J., Brenner, T., Lang, J., Kumle, B., Isgro, F. Anesth. Analg. (2003) [Pubmed]
  33. New light on intravascular volume replacement regimens: what did we learn from the past three years?. Boldt, J. Anesth. Analg. (2003) [Pubmed]
  34. Are lactated Ringer's solution and normal saline solution equal with regard to coagulation?. Boldt, J., Haisch, G., Suttner, S., Kumle, B., Schellhase, F. Anesth. Analg. (2002) [Pubmed]
  35. Clinical review: hemodynamic monitoring in the intensive care unit. Boldt, J. Crit. Care (2002) [Pubmed]
  36. Does coagulation differ between elderly and younger patients undergoing cardiac surgery?. Boldt, J., Haisch, G., Kumle, B., Brosch, C., Lehmann, A., Werling, C. Intensive. Care. Med (2002) [Pubmed]
  37. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?. Boldt, J. Drug. Saf (2002) [Pubmed]
  38. Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function. Boldt, J., Brosch, C., Suttner, S., Piper, S.N., Lehmann, A., Werling, C. Intensive. Care. Med (2002) [Pubmed]
  39. Point-of-care (POC) testing of lactate in the intensive care patient. Accuracy, reliability, and costs of different measurement systems. Boldt, J., Kumle, B., Suttner, S., Haisch, G. Acta. Anaesthesiol. Scand (2001) [Pubmed]
  40. Price development in important anesthesia and critical care medicine journals in comparison to journals of other disciplines. Boldt, J., Maleck, W.H., Fent, T. Acta. Anaesthesiol. Scand (2001) [Pubmed]
  41. Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Boldt, J., Brosch, C., Lehmann, A., Haisch, G., Lang, J., Isgro, F. Ann. Thorac. Surg. (2001) [Pubmed]
  42. Limited Dosage for HES?. Boldt, J. Anasthesiol. Intensivmed. Notfallmed. Schmerzther (2001) [Pubmed]
  43. The good, the bad, and the ugly: should we completely banish human albumin from our intensive care units?. Boldt, J. Anesth. Analg. (2000) [Pubmed]
 
WikiGenes - Universities